BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kei A, Liberopoulos E, Elisaf M. Effect of hypolipidemic treatment on glycemic profile in patients with mixed dyslipidemia. World J Diabetes 2013; 4(6): 365-371 [PMID: 24379928 DOI: 10.4239/wjd.v4.i6.365]
URL: https://www.wjgnet.com/1948-9358/full/v4/i6/365.htm
Number Citing Articles
1
Zhi-bin Wang, Su Zhang, Ya Li, Rong-mei Wang, Ling-chang Tong, Yue Wang, Wei-ye Liu, Ding-feng Su, Ye Tu, Li-chao Zhang, Ling Li. LY333531, a PKCβ inhibitor, attenuates glomerular endothelial cell apoptosis in the early stage of mouse diabetic nephropathy via down-regulating swiprosin-1Acta Pharmacologica Sinica 2017; 38(7): 1009 doi: 10.1038/aps.2016.172
2
Hossein Nikroo, Seyyed Reza Attarzadeh Hosseini, Mehrdad Fathi, Mohammad Ali Sardar, Majid Khazaei. The effect of aerobic, resistance, and combined training on PPAR-α, SIRT1 gene expression, and insulin resistance in high-fat diet-induced NAFLD male ratsPhysiology & Behavior 2020; 227: 113149 doi: 10.1016/j.physbeh.2020.113149
3
Michael S. Kostapanos, Christos V. Rizos, Moses S. Elisaf. Benefit–Risk Assessment of Rosuvastatin in the Treatment of Atherosclerosis and Related DiseasesDrug Safety 2014; 37(7): 481 doi: 10.1007/s40264-014-0169-4
4
T. D. Filippatos, M. S. Elisaf. Pitavastatin and carbohydrate metabolism: what is the evidence?Expert Review of Clinical Pharmacology 2016; 9(7): 955 doi: 10.1586/17512433.2016.1165607
5
Theodosios D Filippatos, Moses S Elisaf. Safety considerations with fenofibrate/simvastatin combinationExpert Opinion on Drug Safety 2015; 14(9): 1481 doi: 10.1517/14740338.2015.1056778
6
Anastazia Kei, Constantinos Tellis, Evangelos Liberopoulos, Alexandros Tselepis, Moses Elisaf. Effect of Switch to the Highest Dose of Rosuvastatin Versus Add‐on‐Statin Fenofibrate Versus Add‐on‐Statin Nicotinic Acid/Laropiprant on Oxidative Stress Markers in Patients with Mixed DyslipidemiaCardiovascular Therapeutics 2014; 32(4): 139 doi: 10.1111/1755-5922.12072
7
Konstantinos Kargiotis, Vasilios G Athyros, Olga Giouleme, Niki Katsiki, Evangelia Katsiki, Panagiotis Anagnostis, Chrysoula Boutari, Michael Doumas, Asterios Karagiannis, Dimitri P Mikhailidis. Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndromeWorld Journal of Gastroenterology 2015; 21(25): 7860-7868 doi: 10.3748/wjg.v21.i25.7860
8
Sebhat Erqou, C. Christine Lee, Amanda I. Adler. Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysisDiabetologia 2014; 57(12): 2444 doi: 10.1007/s00125-014-3374-x
9
Anastazia Kei, Evangelos C. Rizos, Moses Elisaf. Statin use in prediabetic patients: rationale and results to dateTherapeutic Advances in Chronic Disease 2015; 6(5): 246 doi: 10.1177/2040622315596118
10
Vivencio Barrios, Carlos Escobar, Arrigo Francesco Giuseppe Cicero, David Burke, Peter Fasching, Maciej Banach, Eric Bruckert. A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidenceAtherosclerosis Supplements 2017; 24: 1 doi: 10.1016/j.atherosclerosissup.2016.10.003